Back to search

Article

ASCL1 represses a latent osteogenic program in small cell lung cancer in multiple cells of origin

2020-11-11

Abstract excerpt

ASCL1 is a neuroendocrine-lineage-specific oncogenic driver of small cell lung cancer (SCLC), highly expressed in a significant fraction of tumors. However, ~25% of human SCLC are ASCL1-low and associated with low-neuroendocrine fate and high MYC expression. Using genetically-engineered mouse models (GEMMs), we show that alterations in Rb1/Trp53/Myc in the mouse lung induce an ASCL1 + state of SCLC in multiple c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95ef57d4-0810-5255-be18-fe09b748453e
DOI
10.1101/2020.11.11.362632
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ASCL1 represses a latent osteogenic program in small cell lung cancer in multiple cells of originDOI 10.1101/2020.11.11.362632
Select a neighboring publication to make it the new centre.